Skip to main content
Caplight Logo









Allevion Therapeutics

Allevion Therapeutics

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.alleviontx.com/

Last Round

VC Round

Sep 23, 2020

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Allevion Therapeutics is a health care company that develops non-invasive, wearable neuromodulation devices for the treatment of movement disorders such as essential tremor.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuromodulationwearable medical deviceessential tremor treatmentParkinson's diseasemedtechhealth IoTnon-invasive therapytremor reliefdigital healthremote patient monitoringRPMwearable techmovement disordersmart-bandbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allevion Therapeutics Comparables

Compare Allevion Therapeutics with similar companies based on industry and business-model similarity.

Allevion Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Encora Therapeutics
89%
Fasikl, Inc.
84%
Cala Health
82%

Allevion Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 23, 2020
Series AJul 9, 2019
SeedMay 9, 2018

Allevion Therapeutics Investors

Notable investors and investment history

Allevion Therapeutics investors
InvestorRounds
Adventus VenturesVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 2833% to 1.3K.

  • Sep 23, 2020

    Adventus Ventures participated in the VC Round.

Allevion Therapeutics Filings

Explore SEC and related filing metadata, where available.

Allevion Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Allevion Therapeutics's valuation, stock price, and market status.

Is Allevion Therapeutics a public or private company?

Allevion Therapeutics is a private company.

What is the current stock price of Allevion Therapeutics?

Allevion Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Allevion Therapeutics worth (valuation)?

Valuation information for Allevion Therapeutics is not publicly available.

Can I buy Allevion Therapeutics stock?

Allevion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Allevion Therapeutics's last funding round?

Allevion Therapeutics's most recent funding round was VC Round on September 23, 2020.

Who are the main investors in Allevion Therapeutics?

Key investors in Allevion Therapeutics include Adventus Ventures.

Will Allevion Therapeutics IPO soon?

No public IPO plans have been announced for Allevion Therapeutics.

How can I track Allevion Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allevion Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range1
Year Founded2019
Last FundingSep 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?